Fortress Biotech Inc (FBIO) — Cash Flow Reinvestment Rate
Latest as of December 2015:
10.65x
Fortress Biotech Inc (FBIO) has a Cash Flow Reinvestment Rate of 10.65x as of December 2015, reinvesting $30.48 Million (capex $10.64 Million plus investments $19.84 Million) from operating cash flow of $2.86 Million. Check Fortress Biotech Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
10.65x
(Capex + Investments) / Operating CF
Total Reinvested
$30.48 Million
Capex + Investments
Operating Cash Flow
$2.86 Million
USD
Capital Expenditures
$10.64 Million
USD
Annual Cash Flow Reinvestment Rate for Fortress Biotech Inc (None–None)
Year-by-year capital reinvestment analysis for Fortress Biotech Inc. For live market cap and broader valuation context, see Fortress Biotech Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow